Roche gets FDA approval of Xofluza for the prevention of flu following contact with an infected person
November 30, 2020 – Roche (Basel, Switzerland) announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application for Xofluza…